drugset
drugset / Trial / NCT03453320

Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects

NCT03453320 ↗

Phase 4 Completed 12 enrolled University Hospital, Linkoeping
RandomizedCrossoverOpen-labelTreatment

Summary

Treatment with colloidal solutions has during long time been a cornerstone within intensive care. Lately there has been a shift from synthetic colloids to natural albumine. One of these solutions is the hyperoncotic "Albumin 20%". There are however still several aspects of the physiological effects of hyperoncotic albumin, that are not known. In this study the main object is to study with what rate hyperoncotic albumin should be administered. Rapidly 30 minutes or slower 120 minutes.

Timeline

Start
2018-02-24
Primary completion
2019-01-31
Completion
2019-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Albumin Protein / enzyme biologic 3 unknown —

Indications

No indication recorded.